We welcome you to this year's SNMMI Annual Meeting. We look forward to meeting our current and potential partners.
ImaginAb is a clinical stage and revenue-generating biotech company, focused on developing next generation imaging and therapeutic radiopharmaceuticals (RPT) based on our proprietary Minibody and Cys-diabody platform.
We have a clearly defined purpose and growth strategy, which will see us working closely with our research and commercial partners to transform patient care, and help people live better and healtier lives.